Walgreens slashes profit guidance, citing 'challenging' environment for consumers and pharmacies
Walgreens reported fiscal third-quarter earnings that fell short of expectations and slashed its full-year adjusted profit outlook due to a "challenging" environment for pharmacies and U.S. consumers. The company topped revenue estimates for the quarter on strong performance in its health-care segment.
Walgreens Turns $344 Million Profit As CEO Asks Patience On Turnaround
Walgreens Boots Alliance Thursday reported $344 million in its third quarter as chief executive Tim Wentworth asked for patience as the drugstore giant executes its plan for a financial turnaround.
Walgreens Likely To Post A 25% Drop In Q3 Earnings
Walgreens (NASDAQ: WBA) is scheduled to report its fiscal Q3 2024 results on Thursday, June 27 (Walgreens' fiscal ends in August). We expect WBA stock to trade higher post the Q3 announcement, with its revenue and earnings expected to be above the street estimates.
Exploring Analyst Estimates for Walgreens (WBA) Q3 Earnings, Beyond Revenue and EPS
Get a deeper insight into the potential performance of Walgreens (WBA) for the quarter ended May 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Why the Market Dipped But Walgreens Boots Alliance (WBA) Gained Today
Walgreens Boots Alliance (WBA) closed at $15.97 in the latest trading session, marking a +0.63% move from the prior day.
Earnings Preview: Walgreens Boots Alliance (WBA) Q3 Earnings Expected to Decline
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why the Market Dipped But Walgreens Boots Alliance (WBA) Gained Today
In the closing of the recent trading day, Walgreens Boots Alliance (WBA) stood at $15.55, denoting a +0.65% change from the preceding trading day.
How Low Can Walgreens Boots Alliance Stock Go?
Analysts have been downgrading Walgreens shares, but they still see a lot of potential upside. The stock trades at a low earnings multiple and it's right around its book value.
Boots snubs London listing; looks for take-private sale instead
London's stock market suffered another blow when the Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A) revealed it had axed plans to list the British high street pharmacy chain. Hopes for a UK float have been swapped with plots for a sale, with private equity firms believed to be interested in the group, Bloomberg revealed.
Walgreens Boots Alliance (WBA) Surpasses Market Returns: Some Facts Worth Knowing
Walgreens Boots Alliance (WBA) closed at $15.94 in the latest trading session, marking a +0.63% move from the prior day.
Walgreens Looks For Boots Buyers Again As IPO Plans Put On Ice
Walgreens Boots Alliance Inc. is understood to have ditched plans for a potential initial public offering (IPO) of its U.K. drugstore giant Boots.
DOJ settles CityMD Covid fraud allegations for $12 million
Walgreens-backed CityMD will pay $12.04 million to settle Covid fraud allegations brought by the Department of Justice. For two years of the pandemic, CityMD allegedly obtained fraudulent government reimbursements for Covid tests by submitting false claims to a Covid program specifically designated for uninsured patients, even when their patients had health insurance.
